Buscar

Mostrando ítems 1-6 de 6

Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes

2020- Rúa-Figueroa, Iñigo; López-Longo, Francisco J; Del Campo, Víctor; Galindo-Izquierdo, María; Uriarte, Esther; [et al.]

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies

2020- Sanchez-Piedra, C.; Diaz-Torne, C.; Manero, J.; Pego Reigosa, José María; Rua-Figueroa, I.; [et al.]

Semaphorin4A-Plexin D1 Axis Induces Th2 and Th17 While Represses Th1 Skewing in an Autocrine Manner

2020- Carvalheiro, T.; Rafael-Vidal, C.; Malvar-Fernandez, B.; Lopes, A. P.; Pego Reigosa, José María; [et al.]

Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients

2020- Carvalheiro, T.; Lopes, A. P.; van der Kroef, M.; Malvar-Fernandez, B.; Rafael-Vidal, C.; [et al.]

Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases

2020- Rafael-Vidal, C.; Pérez Gómez, Nair; Altabás, I.; Garcia, S.; Pego Reigosa, José María

Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries?

2020- Cortés-Verdú, Raúl; Pego Reigosa, José María; Seoane-Mato, Daniel; Morcillo Valle, Mercedes; Palma Sánchez, Deseada; [et al.]